Meanwhile, the FN1 pathway is well-established to exert significant effects on myocardial fibrosis, aiding the determination of dilated cardiomyopathy etiology and providing a potential therapeutic target [16]. This evidence concerns the gene FN1 and dilated cardiomyopathy.